Search for Clinical Trial Results
Muscular Dystrophies - 49 Studies Found
Status | Study |
Recruiting |
Study Name: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2016-04-28 Interventions:
|
Recruiting |
Study Name: A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2016-04-28 Interventions:
|
Enrolling by invitation |
Study Name: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2017-01-30 Interventions:
|
Not yet recruiting |
Study Name: Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2017-01-27 Interventions:
|
Active, not recruiting |
Study Name: Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Condition: Duchenne Muscular Dystrophy Date: 2015-08-10 Interventions:
|
Recruiting |
Study Name: The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy Condition: Muscular Dystrophy Date: 2015-12-14 Interventions:
|
Completed |
Study Name: Stem Cell Therapy in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-09-12 Interventions: Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Completed |
Study Name: The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies Condition: Muscular Dystrophies Date: 2008-05-06 Interventions: Radiation: Far Infrared Radiation Radiation: Far Infrared Radiation (5μm to 20μm wavelength) F |
Active, not recruiting |
Study Name: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2010-08-17 Interventions:
|
Completed |
Study Name: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2011-04-12 Interventions: Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |